New immunomodulatory glycolipids

Patent number:

EP24382585

Andalucía.svg
No items found.

New tiourea- and urea-based glycolipids with immunomodulatory activity have been efficiently prepared. The compounds are Mincle agonist and have shown in vitro and in vivo immunostimulant activity. They can be used as vacine adjuvants, in the modulation of the immune response and in the treatment of infectious disease or cancer.

Countries:
Spain
Regions:
Andalusia
Centers:
CSIC
Other entities:
Sectors:
Health
Subsectors:
Pharmaceuticals
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

Los nuevos compuestos agonistas de Mincle pueden provocar una respuesta inflamatoria tanto in vitro como in vivo y representan una nueva clase de adyuvantes Th1/Th17. La incorporación de tiourea o urea entre el carbohidrato y las cadenas lipídicas permite protocolos de preparación eficientes y escalables. Pueden utilizarse como adyuvantes en vacunas, en la modulación de la respuesta inmune en un sujeto, o en el tratamiento de enfermedades infecciosas o en el tratamiento del cáncer.

Comments

Other related patents

Health

COMPOSITIONS FOR TREATING DISEASES RELATED TO L YSOME DISORDERS

Countries
Spain
Know more
Health

PYRIDAZIN-3(2H)-ONE DERIVATIVES AS MONOAMINE OXIDASE SELECTIVE ISOFORM B INHIBITORS (AS AMENDED)

Countries
Spain
Know more
Health

Method for expanding stemness and differentiation potential of pluripotent cells

Countries
Spain
Know more
Get back to patents directory